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Introduction: Successful outcome after lower extremity revascularization is usually measured by physician-oriented terms
such as graft patency and amputation-free survival. It has been increasingly appreciated that these criteria do not
necessarily translate into success from the prospective of the patient. The purpose of this study, therefore, is to
retrospectively examine success after lower extremity revascularization for tissue loss using patient-oriented measures and
to include patients who underwent both open surgical bypass and endovascular therapy.
Methods:Between 1998 and 2005, 677 patients (316 endovascular and 361 open surgery) underwent revascularization for
ischemic tissue loss. The method of revascularization (endovascular or open surgery) was left to the discretion of the
surgeon. Revascularization was considered to be clinically successful if each of the following occurred: reconstruction
patency until wound healing, limb salvage for 1 year, maintenance of ambulation for 1 year, and survival for 6 months.
The influence of 20 intrinsic patient factors, including type of revascularization (open vs endo) was examined using the
2 test. Significant factors in bivariate analysis were included in a logistic regression model to determine independent
predictors and probability of failure.
Results:Overall clinical success was achieved in 277 (40.9%) patients. Success for open surgical and endovascular cohorts
was 44.3% and 37.0%, respectively (P .06). Type of intervention was not a significant factor in either bivariate or logistic
regression analysis. Independent predictors of failure (odds ratio [OR]; 95% confidence interval [CI]) regardless of
treatment type included impaired ambulatory status at the time of presentation (OR 3.24; CI 2.14, 4.90), diabetes (OR
1.62; CI 1.14, 2.32), endstage renal disease (ESRD) (OR 1.55; CI 1.07, 2.23), presence of gangrene (OR 2.0; CI 1.42,
2.82), and prior vascular intervention (OR 1.46; CI 1.02, 2.10). Paradoxically, hyperlipidemia (OR 0.70; CI 0.50, 0.98)
was a predictor for success. Probability of failure was 35.4% (OR 1.0) if no independent predictors were present and
increased with the addition of each adverse predictor. For instance, diabetic patients with impaired ambulatory status and
gangrene had an 85.2% (OR 10.5) probability of failure. In the worst case scenario, a diabetic patient with ESRD,
impaired ambulatory status, gangrene, and a prior vascular intervention was considered, probability of failure was a
dismal 92.8% (OR 23.7).
Conclusion: Clinical success after lower extremity revascularization for ischemic tissue loss is determined by intrinsic
patient factors and not by method of revascularization. These data reiterate that future investigation efforts should be
focused less on the method of revascularization and more on identification of patient cohorts at risk for failure regardless
of treatment. (J Vasc Surg 2009;50:534-41.)Successful outcome after lower extremity revasculariza-
tion is usually measured by physician-oriented terms such as
graft patency and amputation-free survival. It has been
increasingly appreciated that these criteria do not necessar-
ily translate into success from the prospective of the patient.
This is particularly true for ischemic tissue loss where re-
search has shown that such patients often experience ex-
tended morbidity and chronic debility after revasculariza-
tion.1-3 In 2006, we examined a cohort of patients with
ischemic tissue loss (ulceration and gangrene), measuring
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534success after bypass as achieving a series of practical objec-
tives obvious to both the physician and the patient.4 In that
report, success (defined as achieving graft patency to the
point of wound healing, limb salvage for 1 year, mainte-
nance of ambulation for 1 year, and survival for 6 months)
was achieved in only 44.4% of patients. However, since
patients with critical limb ischemia are increasingly being
treated by less invasive endovascular means, the relevance
of that report has been questioned. The purpose of this
study, therefore, is to examine success after lower extremity
revascularization for tissue loss using patient-oriented mea-
sures and to include patients who underwent both open
surgical bypass and endovascular therapy.
METHODS
After Institutional Review Committee approval, a ret-
rospective study was designed to calculate the success rate
after surgical bypass. Success was defined as an intervention
which achieved all of the following endpoints: (1) interven-
tional or graft patency to the point of wound healing, (2)
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 3 Taylor et al 535limb salvage for 1 year, (3) maintenance of ambulatory
status for 1 year, and (4) survival for 6 months.
The lower extremity peripheral arterial disease database
of Greenville Hospital System University Medical Center’s
Vascular Teaching Service was reviewed from January 1,
1998, to December 31, 2005, for all cases of lower extrem-
ity ischemic tissue loss (Rutherford Class III) treated with
surgical bypass or endovascular intervention. We identified
677 consecutive patients who underwent technically suc-
cessful unilateral revascularization, whose baseline demo-
graphic characteristics are shown in Table I. Each of the
677 patients who underwent revascularization to a unilat-
eral extremity was analyzed for successful outcome using
the above definition. Of the 677 procedures, 316 were
endovascular interventions and 361 were open bypasses.
Patients who had a concomitant endovascular procedure at
the time of their open operation were considered with the
open operation cohort. When utilizing endovascular inter-
vention as the only means of revascularization, the goal of
Table I. Demographic characteristics of 677 patients
receiving lower extremity revascularization for critical
limb ischemia with tissue loss
Patient characteristics
Percentage (N)
Endo
N  316
Open
N  361 P value
Male 51.27 (162) 60.39 (218) .017
Smoker 57.28 (181) 64.27 (232) .063
Diabetes mellitus 68.04 (215) 67.04 (242) .781
Endstage renal disease 41.77 (132) 25.21 (91)  .001
Coronary artery disease 65.82 (208) 58.45 (211) .049
Hypertension 82.59 (261) 82.55 (298) .987
Hyperlipidemia 38.92 (123) 35.73 (129) .392
Obese (BMI 30) 18.35 (58) 14.13 (51) .135
Chronic obstructive
pulmonary disease 20.25 (64) 19.94 (72) .920
Cerebral vascular accident 20.25 (64) 19.11 (69) .710
CVD 25.32 (80) 22.44 (81) .380
Dementia 14.56 (46) 6.65 (24)  .001
History of prior vascular
surgery 29.75 (94) 32.41 (117) .455
Independent living 90.19 (285) 96.95 (350)  .001
Race
White 75.00 (237) 69.81 (252) .132
Other 25.00 (79) 30.19 (109)
Ambulatory
Ambulatory 64.56 (204) 81.16 (293)  .001
Impaired 35.44 (112) 18.84 (68)
Disease level
AIOD 20.25 (64) 11.91 (43) .003
Infrainguinal 71.84 (227) 82.83 (299)
Both 7.91 (25) 5.26 (19)
Presentation
Gangrene 37.03 (117) 39.89 (144) .445
Ischemic ulceration 62.97 (199) 60.11 (217)
Mean (Std. Dev.)
Age (years) 68.6 (12.0)
AIOD, Aortoiliac occlusive disease; BMI, body mass index;CVD, cardiovas-
cular disease.the operator, typically, was to establish in-line flow to theischemic foot. Therefore, multiple angioplasties were often
performed. Of the 316 endovascular procedures, 227 in-
volved angioplasties of infrainguinal arteries, 64 involved
angioplasties of aortoiliac arteries, and 25 involved angio-
plasties of both aortoiliac and infrainguinal arteries. Of the
361 open operations, there were 98 femoral-popliteal by-
passes, 137 femoral-tibial bypasses, 70 popliteal-tibial by-
passes, 6 tibial-tibial bypasses, 24 aortobifemoral bypasses,
13 iliofemoral bypasses, 9 femoral-femoral bypasses, and 4
axillofemoral bypasses. Type of intervention (open bypass
or endovascular intervention) was performed at the discre-
tion of the attending physician. Typically, more severe
anatomic diseases, such as Trans Atlantic Inter-Societal
Consensus (TASC) classification C or D lesions, were
treated with open bypass where less severe anatomic disease
were treated with endovascular intervention. As well, treat-
ment was often directed according to the Lower Extremity
Grading System (LEGS) score where a LEGS score from
0-9 was treated with open bypass and a LEGS score of
10-19 was treated with endovascular intervention.5 In cases
where subsequent bypass was performed for ischemic
symptoms of the contralateral extremity, the initial proce-
dure was considered the index operation and outcomes
from the non-index operation were excluded from analysis.
When considering the first component of our definition for
success (interventional or graft patency to the point of
wound healing), any endovascular intervention which re-
sulted in an increased ankle-brachial index of at least 0.15
was considered a technical success. Conversely, an ankle-
brachial index which diminished to within 0.15 of the
pre-interventional ankle-brachial index associated with du-
plex scan or angiographic evidence of restenosis was con-
sidered a failed intervention. If the index procedure, be it
open bypass or endovascular intervention, was patent at the
time of wound healing, the intervention was considered a
success. This included interventions or bypasses which may
have undergone adjunctive procedures to maintain patency
(thus the successful definition included bypasses with pri-
mary assisted patency or secondary patency). All patients
have been followed using the protocols established for our
lower extremity database surveillance program, as follows.
The Vascular Surgery Database was established in
1992, registering all cases performed on the vascular sur-
gery teaching service. Since 1998, the year our endovascu-
lar program was initiated, a subset of patients with lower
extremity peripheral arterial disease has been closely scruti-
nized and actively followed. Each lower extremity vascular
procedure is entered on an Excel spreadsheet (Microsoft
Corp, Redmond, Wash). Preoperative demographics are
obtained at presentation and entered into the database.
Functional information to include ambulatory and inde-
pendent living status is also included and information is
updated with each follow-up office visit. Routine follow-up
for infrainguinal bypass grafts includes noninvasive duplex
scan-derived graft flow velocities obtained at 1 month and
every 3 months for the first 18 months and then every 6
months thereafter. Interventions for failing bypass grafts
(intrinsic or juxta anastomotic stenoses with a graft flow
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per second) are performed to restore normal hemodynam-
ics. Patients receiving bypass for aortoiliac occlusive disease
are followed with a patient visit and an ankle-brachial index
study at 1-month and then at 6-month intervals. Patients
receiving an endovascular procedure are assessed with
ankle-brachial index within 1 month of intervention and
followed-up with repeat ankle-brachial index every 6 months.
In patients with tissue loss, office visits for wound manage-
ment are scheduled as needed.
In addition to information obtained at each follow-up
visit, the database is scrutinized each summer by indepen-
dent research workers looking for missing data points or
missing patients. Sources used to attain follow-up include
the hospital computerized Lifetime Clinical Record, the
computerized radiology Picture Archiving Communica-
tion System (PACS), and the online obituary services of all
state-wide newspapers. Using the above, follow-up was
completed on all 677 patients studied.
For the purpose of this study, the clinical course of each
patient was reviewed and measured using the four defined
parameters of clinical success (graft patency to the point of
wound healing; limb salvage for 1 year; maintenance of
ambulatory status for 1 year; and survival for 6 months).
Only patients who achieved all four of the criteria were
considered to have had a successful outcome. The clinical
success rate was then calculated for all 677 patients as well
as the 316 patients undergoing endovascular intervention
and the 361 patients undergoing open bypass. Next, the
influence of a series of patient factors and comorbidities on
clinical success was analyzed using bivariate and multivari-
ate logistic regression analysis. Factors analyzed included
age, gender, ethnicity, history of cigarette smoking, pres-
ence of diabetes, presence of endstage renal disease, pres-
ence of coronary artery disease (moderate to high risk as
scored by the Eagle criteria),6 the presence of hypertension,
the presence of hyperlipidemia, obesity (body mass index
[BMI] 30), the presence of chronic obstructive pulmo-
nary disease, a history of cerebrovascular accident, a history
of associated cerebrovascular disease, a history of dementia,
history of prior vascular surgery, independent living status,
preoperative ambulatory status, the level of atherosclerotic
disease (aortoiliac vs infrainguinal), presentation (ischemic
ulcer vs gangrene) and type of intervention (endovascular
or open bypass). In our database, preoperative ambulatory
status is characterized as ambulatory (independent ambu-
lation out of house), ambulatory/homebound (ambula-
tory in home only), nonambulatory/transfer (eg, uses legs
to transfer from bed to chair or from the chair to the
commode), or nonambulatory/bedridden. In each case,
ambulatory status is determined by physical conditions
thought to be independent of their vascular disease. Thus,
ambulatory status is defined as the patient’s functional
status immediately before the development of vascular
symptoms. With this definition, ambulatory impairment is
usually a function of other medical comorbidities such as
arthritis, sequelae of cerebrovascular and cardiovascular
disease, or advanced age. For the purpose of the study, wegrouped patients classified as ambulatory/homebound or
nonambulatory/transfer only together, and termed them
as “impaired ambulatory status”. None of the 677 patients
in the study had the preoperative classification of nonam-
bulatory/bedridden. As well, for the purpose of this study,
a change in ambulatory status was defined as a permanent
postoperative change in ambulatory classification, despite
full recovery from surgery (eg, ambulatory to impaired
ambulatory status).
Lastly, comorbidities found to be significant in bivari-
ate analysis were studied using logistic regression analysis to
determine independent predictors of failure. Odds ratios
(ORs) and 95% confidence intervals (CIs) were calculated.
Since the type of intervention (endovascular intervention
or open bypass) was of particular interest, this was included
in the full logistic regression model as well. Additionally,
any variables that were significant in bivariate analysis when
independently examining the open and endovascular sur-
gery subgroups were also included in the full model. After
determining these independent predictors of failure, prob-
ability of failure (%) was calculated for each predictor and
for combinations of predictors.
Statistical analysis. The 2 tests were used for bivari-
ate analyses of failure and categorical patient characteristics,
while t test was used for comparing mean age of successes
and failures. Logistic regression was used to model the
likelihood of a failed outcome given specific patient char-
acteristics. The ORs and 95% CIs were estimated. All
variables that were significant in the bivariate analyses were
included in the full model. Probability of failure (%) was
determined using logistic regression. The data analysis was
generated using SAS software, v 9.1.3 of the SAS System
(SAS Inc, Cary, NC).
RESULTS
Follow-up was complete for all 677 patients. Table II
shows results from each of the four measures of clinical
success listed separately and in combination. If the four
determinants were considered separately, then success after
bypass ranged from 43.6% (patency to the point of wound
healing) to 84.6% (survival for 6 months). However, if all
parameters were combined, clinical success was achieved in
Table II. Independent and combined measures of
success for 677 patients receiving lower extremity
revascularization
Outcome parameter
Number
successful (%)
Number
failed (%)
Intervention patency to the
point of healing 295 (43.6) 382 (56.4)
Limb salvage for 1 year 512 (75.6) 165 (24.3)
Maintenance of ambulatory
status for 1 year 572 (84.5) 105 (15.5)
Survival for 6 months 573 (84.6) 104 (15.4)
Clinical outcome
combining all parameters 277 (40.9) 400 (59.1)only 40.9% of patients (n  277/677). When considering
Ischemic ulceration 52.16 (217)
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achieved in 44.3% (n  160/361) of patients undergoing
open bypass and 37% (n 117/316) of patients undergo-
ing endovascular intervention, a difference (P  .05) al-
most reaching statistical significance (defined as P  .05).
While the need for contralateral vascular intervention was
considered a neutral occurrence in our definition of clinical
success, it is noteworthy that no patient experienced clinical
failure because of a mortality or permanent loss of ambula-
tory ability as a result of the contralateral intervention.
Of the four components comprising the definition,
“patency to the point of wound healing” was the most
discriminatory element (43.6% overall success). Analysis of
this component showed that while 494/677 (73%) inter-
ventions remained patent during the study period, only
295 foot wounds healed; an additional 12 wounds healed
with a failed revascularization. Patency was similar for open
surgery and endovascular intervention (273/361 [75.6%])
and (221/316 [69.9%], respectively; P .097). However,
wound healing, though not impressive for either therapy,
was significantly better for open surgery (171/361 [47.4%])
when compared to endovascular intervention (124/316
[39.2%]) (P .033).
The influence of patient comorbidities on the success
rate for the entire cohort of 677 patients is shown in Table
III. Statistically significant predictors of poor outcome
using bivariate analysis included the presence of diabetes
mellitus, the presence of endstage renal disease, the diag-
nosis of dementia, a history of prior vascular surgery, inde-
pendent living status, impaired ambulatory status at presen-
tation, the presence of infrainguinal disease requiring
bypass (as opposed to aortoiliac occlusive disease), and the
presence of gangrene. When success rates were considered
separately for the 361 patients treated with open bypass and
the 316 patients treated with endovascular intervention
using bivariate analysis, the statistically significant predic-
tors of poor outcomewere similar to those identified for the
entire cohort (Table IV). Bivariate analysis identified eight
statistically significant predictors of outcome for the entire
cohort (n 677), eight statistically significant predictors of
outcome for the open surgery cohort (n  361), and five
statistically significant predictors of outcome for the endo-
vascular cohort (n 316). The only unique predictor in the
open surgery group not found in the entire cohort was
hyperlipidemia. The only unique predictor in the endovas-
cular group not found in the entire cohort was hyperten-
Table III. Continued
Characteristic
Percentage with
failure (n) P value
Age
Mean age for successes 68.8 (Std. Dev.: 12.2) .67
Mean age for non-successes 68.4 (Std. Dev.: 11.8)
AIOD, Aortoiliac occlusive disease; BMI, body mass index.
*denotes statistically significant at alpha  0.05.Table III. Bivariate analysis of patient factors and
comorbidities of failure after revascularization using a
patient-oriented definition of success
Characteristic
Percentage with
failure (n) P value
Type
Open 55.68 (201) .05
Endo 62.97 (199)
Gender
Female 57.09 (169) .33
Male 60.79 (231)
Race
White 57.67 (282) .23
Other 62.77 (118)
Smoker
Yes 58.60 (242) .75
No 59.85 (158)
Diabetes mellitus
Yes 63.68 (291)  .01*
No 49.55 (109)
Endstage renal disease
Yes 70.40 (157)  .01*
No 53.42 (242)
Coronary artery disease
Yes 61.34 (257) .13
No 55.43 (143)
Hypertension
Yes 60.64 (339) .07
No 51.69 (61)
Hyperlipidemia
Yes 55.16 (139) .11
No 61.41 (261)
Obese (BMI 30)
Yes 54.13 (59) .25
No 60.04 (341)
Chronic obstructive pulmonary
disease
Yes 63.24 (86) .27
No 58.04 (314)
Cerebral vascular accident
Yes 57.14 (76) .61
No 59.56 (324)
Cardiovascular disease
Yes 59.01 (95) .98
No 59.11 (305)
Dementia
Yes 75.71 (53)  .01*
No 57.17 (347)
History of prior vascular surgery
Yes 66.35 (140) .01*
No 55.79 (260)
Independent living status
Independent 57.95 (368) .02*
Non-Independent 76.19 (32)
Ambulatory
Ambulatory 51.91 (258)  .01*
Impaired ambulation 78.89 (142)
Disease level
AIOD 44.86 (48)  .01*
Infrainguinal 61.98 (326)
Both 59.09 (26)
Presentation
Gangrene 70.11 (183)  .01*sion. Statistically significant independent predictors of fail-
JOURNAL OF VASCULAR SURGERY
September 2009538 Taylor et alure, ORs, and 95% CIs were calculated using multivariate
logistic regression analysis. All significant predictors in bi-
variate analysis (P  .05) for the entire cohort, the open
surgery cohort (ie, hyperlipidemia), and the endovascular
cohort (ie, hypertension) were included in the full model.
This included “type of treatment” (endovascular vs open
surgery; P .5) as well. Results (OR; 95% CI) showed that
statistically significant patient predictors of failure after
revascularization included impaired ambulatory status at
presentation (OR 3.24; CI 2.14, 4.90), the presence of
diabetes (OR 1.62; CI 1.14, 2.32), the presence of end-
stage renal disease (OR 1.55; CI 1.07, 2.23), the presence
of gangrene (OR 2.0; CI 1.42, 2.82), and a history of prior
vascular intervention (OR 1.46; CI 1.02, 2.10). The pres-
ence of hyperlipidemia paradoxically was an independent
predictor of success (OR 0.70; CI 0.50, 0.98). Of note,
“type of treatment” when entered into the logistic regres-
sion model and refined by backward selection (selection
criteria  0.05), fell quickly out of the equation, empha-
sizing that method of revascularization did not predict
successful outcome.
Finally, the probability of failure for each independent
predictor, alone and in combination, is shown in Table V. If
no independent predictors of failure were present at the
time of revascularization, the probability of failure was
35.4% (OR 1.0). While the probability of failure increased
Table IV. A comparison of bivariate results by procedure
type (bivariate analysis of patient characteristics and
success/failure outcome using 2 test)
Characteristic
P value
Overall
N  677
Endo
N  316
Open
N  361
Type .05 — —
Gender .33 .06 .88
Race .23 .16 .59
Smoker .75 .48 .36
Diabetes mellitus  .01* .01* .02*
Endstage renal disease  .01*  .01* .04*
Coronary artery disease .13 .14 .59
Hypertension .07 .04* .56
Hyperlipidemia .11 .90 .02*
Obese (BMI 30) .25 .87 .10
Chronic obstructive
pulmonary disease .27 .84 .19
Cerebral vascular
accident .61 .21 .67
Cardiovascular disease .98 .37 .46
Dementia  .01* .18  .01*
History of prior vascular
surgery .01* .08 .05*
Independent living status .02* .08 .25
Ambulatory  .01*  .01*  .01*
Disease level  .01* .11  .01*
Presentation  .01* .01*  .01*
Age .67 .50 .65
BMI, Body mass index.
*Denotes statistically significant at alpha  .05.significantly when associated with each independent pre-dictor; the presence of multiple predictors had particularly
poor prognoses. For example, if a patient presented with all
six independent predictors, the probability of failure was
90.1%. Patients presenting with every independent predic-
tor of adverse outcome (impaired ambulation at presenta-
tion, the presence of diabetes, the presence of endstage
renal disease, gangrene as opposed to ischemic ulceration,
and a prior vascular intervention) experienced only a 7.2%
chance of success.
DISCUSSION
Since its original description, operative bypass for
chronic lower extremity ischemia has been evaluated by
measuring graft patency and limb salvage. It is intuitive to
believe that accomplishing these objectives should translate
into a successful outcome. However, in the late 1990s, a
series of reports emerged suggesting that graft patency and
limb salvage only tell part of the story. Specifically, reports
from the University of Oregon showed that patients under-
going bypass for critical limb ischemia had a frequent
ongoing need for care, with prolonged periods of wound
healing and subsequent operations to maintain graft
patency.1,2 In their large registry of patients, only 14% had
an uncomplicated operation, relief of symptoms, complete
wound healing, no need for repeat operation, and mainte-
nance of functional status. For the remaining 86% of pa-
tients, a major portion of their remaining lives were spent
with ongoing treatment for critical limb ischemia. These
papers had a profound impact on the vascular community,
causing many to question our current approach to limb
salvage. Acknowledging that much of the early literature
devoted to critical limb ischemia measured success after
revascularization using physician-oriented endpoints and
not patient-oriented endpoints, the leadership in vascular
Table V. The probability of failure for each independent
predictor of failure alone and in combination
Patient characteristic(s)
present
Probability of
failure (%)
Odds ratio of given
profile compared to
a “healthy” person*
(#1) Impaired ambulation
at baseline 64.0% 3.2
(#2) Diabetes 47.1% 1.6
(#3) ESRD 45.9% 1.5
(#4) Hyperlipidemia 27.7% 0.7
(#5) Gangrene 52.3% 2.0
(#6) Prior vascular
intervention 44.4% 1.5
Predictive variables #1-6 90.1% 16.5
Predictive variables
#1,2,3,5,6 92.8% 23.7
Predictive variables #1,2 74.2% 5.3
Predictive variables #1,2,3 81.7% 8.1
Predictive variables #5,6 61.5% 2.9
Predictive variables #1,2,5 85.2% 10.5
Predictive variables #2,3 57.9% 2.5
Baseline/“healthy person” 35.4% 1.0
ESRD, Endstage renal disease.surgery recently published a directive in a supplement of the
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of patient-oriented endpoints as a major future research
objective.7 In response, our group published a study exam-
ining 331 patients who underwent lower extremity bypass
for tissue loss where we measured success as achieving
bypass patency until wound healing, limb salvage for 1 year,
maintenance of ambulatory status for 1 year, and survival
for 6months. In that report, clinical success was achieved in
only 44% of patients. Independent predictors of failure
included impaired ambulatory status at presentation, end-
stage renal disease, the need for an infrainguinal bypass, and
the presence of gangrene (as opposed to ischemic ulcer-
ation).4
Since publishing that report, we have received much
constructive and critical feedback. Criticism has been levied
in two areas; the arbitrary nature of our definition for
success, and the exclusion of patients undergoing endovas-
cular intervention for ischemic tissue loss. Admittedly, our
definition of success is entirely arbitrary. In establishing the
definition, we wanted to take a perspective from the pa-
tient’s point of view and, thus, constructed a common sense
description of success that would be obvious to everyone.
However, we wanted the definition to be fair and within a
reasonable realm of medical attainability. The first compo-
nent, patency to the point of healing, intuitively meets
these criteria. Our intent with this component was to
measure treatment effectiveness (successful relief of isch-
emia such that healing occurred). If an intervention were to
thrombose and patency not re-established prior to healing,
or if a wound failed to heal despite a patent intervention, it
would be obvious that the intervention was a failure. Con-
versely, if an intervention were to fail but a wound healed
anyway, some might consider the original intervention as
unnecessary. The second and third components, limb sal-
vage and maintenance of ambulatory status for 1 year,
though temporally arbitrary, met criteria and seemed rea-
sonable. The final component, survival for 6 months, has
been particularly scrutinized. In establishing this compo-
nent, our intention was to utilize mortality as a measure of
perioperative patient safety, not necessarily a measure of
patient longevity. Clearly, a successful intervention should
result in a low mortality. Any mortality after 6 months, we
reasoned, was most likely not related to the intervention.
However, long-term survival for patients with ischemic
tissue loss is poor. Mortality for patients with critical limb
ischemia is roughly 6% per year.8 In a report from our
institution looking exclusively at patients with tissue loss,
5-year survival was only 29%.9 We, therefore, felt that any
definition of success tied in any way to long-term survival
may not be readily achievable and, thus, is probably unfair.
Therefore, we chose survival for 6 months as the final
component of our definition.
We have come to believe that the criticism attributed to
our exclusion of patients undergoing endovascular inter-
vention for ischemic tissue loss is valid and, consequently,
became themotivation for this study. Endovascular therapy
has increasingly become initial therapy for many patients
with critical limb ischemia. Examination of our currentdatabase demonstrates this. Nearly half of the patients with
ischemic tissue loss were treated initially with endovascular
intervention. Endovascular intervention carries a lower
morbidity and mortality and, while it is less durable than
open bypass, theoretically results in situational perfusion
capable of healing ischemic ulcers. Clearly, including endo-
vascular intervention cases into this current analysis appears
to be a reasonable proposition and, therefore, more accu-
rately depicts the current practice of most vascular sur-
geons. In doing so, this study contains a more robust
number of patients than our original report and allows
comparison between patients undergoing endovascular in-
tervention and open bypass. We found that when combin-
ing open bypass with endovascular intervention, overall
success as defined was 40.9%. Though postulated by some,
patients treated with less invasive endovascular therapy did
not fare better than patients treated with open surgery. To
the contrary, the open surgery cohort experienced overall
success in 44% of patients compared to 37% of endovascular
patients, a difference approaching statistical significance
(P  .05). Clearly, the retrospective nature of this study
with its acknowledged treatment bias precludes a head-on-
head comparison of success rate for open and endovascular
surgery in a general sense. All we can conclude is that
patients that we chose to treat with open surgery (be it on
the basis of the TASC classification or the LEGS score) did
as well, or perhaps a little better, than patients we chose to
treat with endovascular therapy.
When considering our definition for success, outcome
was most prominently dictated by the percentage of pa-
tients unable to achieve interventional patency until the
point of wound healing. Of patency and wound healing,
wound healing was the most discriminatory component of
success, occurring in only 39% of patients after endovascu-
lar intervention. Independent predictors of failure were
similar to our first report and were similar regardless of
which type of initial therapy (open bypass or endovascular
therapy) was employed. Independent predictors of failure
included impaired ambulation at presentation, endstage
renal disease, prior vascular surgery, the presence of gan-
grene as compared to ischemic ulceration, and diabetes. If
no independent predictors of failure were present, the
probability of success after intervention or bypass was
nearly 65%, and if all adverse predictors of failure were
present, the probability of success after intervention or
bypass was only 7%. At first glance, a success rate of only
65% in the absence of independent predictors of failure
seems disappointing. However, given that these patients
face certain major limb amputation without revasculariza-
tion, a certain degree of “failure” may be clinically accept-
able in order to attempt limb salvage. We believe these
results can be more appropriately used as a clinical tool for
discussion with families and patients at the bedside on the
opposite end of the clinical spectrum; when various inde-
pendent predictors of failure are present and the clinical
course favors palliative primary amputation. Given that
revascularization is expensive, potentially morbid, and
labor-intensive for all involved, our model assigns numeri-
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especially situations where outcomes appear subjectively
futile.
The study has all the shortcomings of any retrospective
study. Treatment was not standardized. Results are from a
single center. The definition of success has not been derived
from consensus. Our study included only patients felt wor-
thy of revascularization. It excluded patients where primary
amputation was felt to be the best initial course. Thus, our
success rate of 40.9% represents a sobering “best case
scenario.” While the results of the study help define success
and failure for patients with ischemic tissue loss when no
predictors or multiple predictors are present, they may
create conflict when only one or two are identified. For
example, when patients present with gangrene and a prior
vascular intervention as the only two predictors, the prob-
ability of failure is approximately 60%. Conversely, the
probability of success is nearly 40%. While these odds for
success may not be particularly encouraging, they are not
exactly futile either. Thus, in this instance, our model is not
very helpful in directing therapy or advising families as to
the best medical course based on odds of success. Clearly,
more work is needed to better understand which patients
achieve benefit after revascularization and which do not. To
this regard, our study simply scratches the surface.
An additional finding in both this and our former study
is the seemingly protective effect of hyperlipidemia (OR
0.70). The reason for this is unknown. For the purposes of
this study, a patient was designated as having hyperlipid-
emia if an International Classification of Disease (ICD)-9
diagnosis code for hyperlipidemia was assigned to the pa-
tient’s clinical record. Lab work indicative of hyperlipid-
emia suggests that these patients have undergone some
type of cardiovascular screening and, by conjecture, are
probably more conscientious about their own healthcare.
Most of these patients were on statin therapy, providing
further evidence that cardiovascular disease management
was ongoing. Thus, the apparent protective effect of hyper-
lipidemia may be a function of better access to routine
health maintenance or may represent a protective affect
afforded by statin therapy. Further investigation is needed.
Lastly, our study exposes two clinical problem areas signif-
icantly impacting success after lower extremity revascular-
ization. As with our previous studies, patients who present
with impaired ambulatory status and lower extremity isch-
emic tissue loss perform particularly poorly.4,10 Further
prospective study examining the appropriate care of func-
tionally impaired patients is needed to help better direct
appropriate therapy. It appears in some situations that
palliative care without revascularization is warranted. Also,
this study found that the healing of foot wounds was of
particular concern. Healing occurred in roughly half the
patients undergoing open bypass and in just over one third
of patients undergoing endovascular intervention, a differ-
ence that was statistically significant. Investigation correlat-
ing the extent of foot wound involvement and expected
outcomes is needed. Evidence from this study suggests that
there may be limbs with foot wounds traditionally consid-ered to be salvageable that, indeed, may not be salvageable,
especially if endovascular intervention is the revasculariza-
tion method utilized.
In summary, we believe this study supports the follow-
ing observations. First, success from the patient’s perspec-
tive is clearly different than success from the surgeon’s.
Future treatment options probably need to consider both.
Using our patient-oriented definition, successful outcome
after revascularization for tissue loss was a modest 40.9%.
Next, our study shows that patients selected for open
bypass do as well or perhaps a little better than patients
selected for endovascular intervention.While the retrospec-
tive nature of this study with its inherent treatment selec-
tion bias precludes head-on-head comparison, it is reason-
able to deduce that open surgery and endovascular therapy
are complementary, not competitive techniques capable
of achieving similar success rates when employed in appro-
priate situations. There are clinical scenarios where neither
technique is appropriate and where palliation without re-
vascularization is indicated. That would include primary
amputation. Lastly, future research should be geared less
toward developing new revascularization strategies that
compare endovascular intervention to open bypass and
more toward defining goals of treatment after revascular-
ization. Success or failure in many cases appears to depend
on the patient’s overall physical and functional condition at
presentation, to include the extent of foot wound involve-
ment, and not on the vascular status of the affected limb.
Indeed, our data would suggest that ischemic tissue loss,
especially gangrene, is a precursor to overall patient demise
in many cases. As our failing healthcare system endures
increasing financial scrutiny, identification of patient co-
horts incapable of achieving benefit from revascularization
is desperately needed. Studies identifying such cohorts will
be invaluable and will allow us to appropriately allocate our
diminishing resources to achieve the greater good.
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Dr David M. Minion. Thank you and I would like to
congratulate Dr York and the Greenville group on another out-
standing and very thought provoking study. I would also like to
thank them for forwarding the manuscript to me in a timely
manner. It has allowed me to begin the Prozac (Eli Lilly & Co,
Indianapolis, Ind) very early and after nearly 2 weeks of this
medication, I rarely lapse into a catatonic state. It has been over 72
hours since I have spontaneously broke down and began learning
the phrase “mywhole existence is a sham” repeatedly, but I digress.
This study is an important one in that it once again emphasizes or
highlights that rest pain and tissue loss clearly are two separate
entities even though they are often lumped together in terms of
critical limb ischemia.When you focus simply on people with tissue
loss, it is just an extremely challenging cohort of patients, again I
think you have illustrated that well. The paper is also very impor-
tant because it highlights that limb salvage and wound healing are
two different entities. Seventy-three patency rate correlated well
with the 76% limb salvage rate, but wound healing was a soberingpatency and wound healing; in other words, why aren’t these
wounds healing? Are there anatomic factors that you might, for
example, pedal disease as you might hypothesize, might explain
this difference, and perhaps more importantly, do we as vascular
surgeons need to focus more research efforts on advancing wound
care in further efforts for further success with these patients?
Dr York. Thank you for your comments. That number (44%)
struck us as being very odd as well and clearly was out of line with
the other findings that we had. Clearly, there is more to wound
healing than simple revascularization. Often times, patients are not
very compliant, they are not off loaded adequately, and they have
inadequate nutrition, ultimately leading to poor wound healing.
There are a lot of factors that go into the actual healing of
neuropathic wounds or gangrene, so I can’t answer the question
specifically, but again there is more to it than revascularization
alone. Our belief is that discriminating patient selection may be the
single most important consideration in achieving successful out-
comes in patients with tissue loss.
